| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 3 |
| 1 | BISOPROLOL FUMARATE | 3 |
| 2 | LISINOPRIL | 3 |
| 3 | DIGOXIN | 2 |
| 4 | DUPILUMAB | 2 |
| 5 | FUROSEMIDE | 2 |
| 6 | IDURSULFASE | 2 |
| 7 | LAMIVUDINE | 2 |
| 8 | LAMIVUDINE ORAL | 2 |
| 9 | NEVIRAPINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIFOSTINE | 1 | 0.0012 |
| 1 | IDURSULFASE | 2 | 0.0005 |
| 2 | NEVIRAPINE | 2 | 0.0002 |
| 3 | ZIDOVUDINE | 2 | 0.0002 |
| 4 | LUBIPROSTONE | 1 | 0.0001 |
| 5 | CEFUROXIME | 1 | 0.0001 |
| 6 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 7 | LAMIVUDINE | 2 | 0.0001 |
| 8 | DIGOXIN | 2 | 0.0000 |
| 9 | DOXAZOSIN MESYLATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 1 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Cardiac Glycoside [EPC] | 2 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Anti-IgE [EPC] | 1 | 0.0000 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 3 | 0.0000 |
| 8 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 9 | Calcium [EPC] | 1 | 0.0000 |